Swapnroop Drugs & Pharmaceuticals is a Recaticimab API manufacturer, supplier, and exporter in India, offering Recaticimab biologic active pharmaceutical ingredient and pharmaceutical sourcing support for formulation development, biopharmaceutical research, analytical requirements, and international pharmaceutical projects.
Recaticimab is a monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9, commonly known as PCSK9. It is associated with lipid-lowering therapeutic applications and pharmaceutical development for hypercholesterolemia and dyslipidemia.
We focus on consistent product quality, controlled sourcing, batch-to-batch reliability, appropriate biologic handling, and comprehensive technical documentation. Recaticimab API requirements can be supported according to customer-specific quality parameters and applicable biopharmaceutical specifications.
We support Recaticimab API and biologic active substance requirements for pharmaceutical formulation companies, biopharmaceutical organizations, contract research organizations, research institutions, pharmaceutical distributors, and authorized international buyers.
Our Recaticimab API supply services support:
Recaticimab API is evaluated according to applicable biologic quality parameters, analytical methods, product specifications, and customer requirements.
Typical Quality Parameters Include:
Appearance: Clear to slightly opalescent solution or as per specification
Identification: Complies with specification
Protein Concentration: As per approved specification
Purity: As per specification
Purity by SEC-HPLC: As per approved specification
Charge Variants: Within specified limits
High Molecular Weight Species: Within specified limits
Low Molecular Weight Species: Within specified limits
Binding Activity: As per validated biological assay
Biological Activity / Potency: As per approved specification
PCSK9 Binding Activity: As per specification
pH: As per approved specification
Endotoxin: Within specified limits
Bioburden: As applicable
Sterility: As applicable
Host Cell Protein: Within specified limits
Residual Host Cell DNA: Within specified limits
Residual Protein A: Within specified limits, as applicable
Particulate Matter: As per applicable requirements
Actual specifications may vary depending on manufacturing process, expression system, purification process, formulation, analytical methods, intended use, development stage, regulatory requirements, and customer-approved specifications.
Recaticimab API is associated with the biopharmaceutical industry as a monoclonal antibody active substance targeting PCSK9.
Recaticimab is a PCSK9 inhibitor associated with lipid-lowering pharmaceutical products and therapeutic development for hypercholesterolemia and mixed dyslipidemia.
Its biological activity is associated with binding to PCSK9 and preventing PCSK9-mediated degradation of low-density lipoprotein receptors. Increased availability of LDL receptors on cell surfaces supports enhanced clearance of low-density lipoprotein cholesterol from circulation.
Recaticimab API is primarily intended for use by licensed biopharmaceutical manufacturers, formulation development companies, biotechnology organizations, research institutions, contract research organizations, and authorized pharmaceutical organizations.
Swapnroop Drugs & Pharmaceuticals offers reliable Recaticimab API sourcing and supply support for domestic and international biopharmaceutical requirements.
Our Key Advantages:
We support the export and international supply coordination of Recaticimab API and biologic pharmaceutical materials from India to pharmaceutical companies, biotechnology organizations, research institutions, distributors, and authorized buyers across international markets.
Export documentation and product information can be provided based on destination-country requirements, customer specifications, intended use, cold-chain requirements, and applicable regulatory procedures.
We serve pharmaceutical and biopharmaceutical buyers across Asia, Africa, the Middle East, Latin America, and other international pharmaceutical markets.
Looking for a reliable Recaticimab API manufacturer in India, Recaticimab API supplier in India, or Recaticimab API exporter from India?
Contact Swapnroop Drugs & Pharmaceuticals for Recaticimab API requirements, technical documentation, COA, SDS, pricing, packaging details, biologic handling information, and export inquiries.
Company: Swapnroop Drugs & Pharmaceuticals
Product: Recaticimab API
CAS Number: 2361290-85-7
Supply Type: Biologic API / Monoclonal Antibody Active Substance
Country of Origin: India
Email: enquiry@sdp.org.in